Results 91 to 100 of about 881,385 (277)
Non-staphylococcal infections of cardiac implantable electronic devices
Background. The number of infections of cardiac implantable electronic devices (CIED) continues to escalate out of proportion to the increase rate of device implantation. Staphylococcal organisms account for 70% to 90% of all CIED infections.
Viola, George M
core +1 more source
A new class of Cu, Ni bimetallic 2D cMOF (CuNi‐HHTP 2D cMOF) featuring dual catalytic sites and high delocalized electronic structure for boosting POD performance. The CuNi‐HHTP 2D‐cMOF enhances the conversion kinetics of H2O2 to ROS, which subsequently enhances antibacterial activity and accelerates the healing of oral ulcers, with macroscopic wound ...
Yixuan Lu +9 more
wiley +1 more source
Staphylococcal and streptococcal infections
Staphylococci and streptococci are leading causes of healthcare and community-acquired bacterial infections worldwide. Within each genus, virulent species such as Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae are associated ...
James Price (16652433) +2 more
core +1 more source
A rigid‑flexible integrated CO depot is engineered by embedding rigid COFQDs into a flexible ECM gel network. The rigid framework enables high‑capacity CO storage and sonodynamic bacterial killing, while the flexible ECM gel controls sustained CO release, collectively eradicating multidrug‑resistant infection and promoting scarless healing.
Baohong Sun +13 more
wiley +1 more source
ObjectivesStaphylococcal small-colony variants (SCVs) are common in cardiac implantable electronic device (CIED) infections. This is the first retrospective and multi-case study on CIED infections due to staphylococcal SCVs, aiming to provide a ...
Si Liu +7 more
doaj +1 more source
Objective: Seasonal variations in temperature exert strong selective pressure on microorganism population dynamics and should be taken into account in epidemiological studies.
T. Delorme, A. Garcia, P. Nasr
doaj +1 more source
Vaccines and Immunotherapy for Staphylococcal Infections
Nosocomial or hospital-acquired infections are associated with prolonged hospitalizations and increased healthcare costs. Infections associated with surgical implants are becoming more difficult and more costly to manage, as they require repeated ...
J.M. Patti
core +1 more source
Through AI‐assisted screening from FDA‐approved API to overcome the limitations of bacterial osteomyelitis treatment, glycyrrhizic acid and simvastatin are identified as a multifunctional combination capable of self‐assembling into mechanism‐targeting nanocrystals that effectively neutralize reactive oxygen species, suppress M1 macrophage polarization,
Yu Han +11 more
wiley +1 more source
This study unveils a novel antibacterial mechanism against MRSA, in which the compound Py‐27 selectively targets and inhibits aspartate transcarbamoylase (ATCase), a key enzyme in pyrimidine synthesis. This inhibition disrupts DNA replication, induces oxidative damage, leading to potent bactericidal activity.
Xiaorong Yang +11 more
wiley +1 more source
Studies in the pathology of staphylococcal infections [PDF]
The current trend, in the investigation of staphylococcal infections is to concentrate attention on the bacterium and. its products. Not only does the bacterium receive most attention, but also the prevalent tendency is to experiment in vitro.
Powell, David E. B.
core +3 more sources

